Navigation Links
Resonant Medical Appoints New Vice President of Global Sales
Date:9/10/2007

MONTREAL, Sept. 10 /PRNewswire/ - Resonant Medical, the world leader in 3D ultrasound image-guided adaptive radiotherapy products, announced today that Mr. Joe Redfearn has joined the Company as Vice President Global Sales. This is a new position for Resonant Medical, and in this role, Mr. Redfearn will be responsible for the Company's global sales and customer support activities. He will also contribute to the expansion of the international distribution network.

"Mr. Redfearn brings to Resonant a track record of successful capital equipment sales and support management," said Steve Arless, Resonant's president & CEO. "His experience in the US and international marketplaces will help us achieve our bold goals for the coming years.

Mr. Redfearn joins the Company from Stereotaxis, where he was Vice-President of Capital Sales. He is a seasoned executive that has grown in the medical device industry for over 25 years, where he has worked for CryoCath Technologies, ThermoCardio Systems and CR Bard. "I'm excited to join the Resonant Medical Team and look forward to leading Resonant's efforts toward profitable revenue growth" commented Redfearn. "With new top management and proven product performance, Resonant is well-positioned for significant sales growth."

About Resonant Medical and Restitu(TM)

Resonant Medical Inc. is the world leader in 3D ultrasound image-guided radiotherapy products designed to improve treatment planning, verification and delivery. Recently, the company secured significant financing in order to develop and market Restitu(TM) add-on modules that will improve the quality of radiotherapy treatment for patients with breast, head & neck, cervix, bladder, and other soft tissue malignancies. These modules will compliment the previously released prostate module and Restitu(TM) platform, which are already in use in dozens of cancer clinics and university hospitals in North America.

The Restitu(TM) Platform accurately visualizes and corrects daily changes in tumor position, shape and size, thus ushering in a new era of 3D ultrasound (U/S) multimodality radiotherapy treatment planning and image guidance. Installed in CT-Sim rooms, Restitu U/S-Sim(TM) allows for better definition of planning tumor volumes with its patented IMPLICIT REGISTRATION(TM) technology that automatically fuses 3D U/S to CT data. With U/S-Sim, multimodality treatment planning has now been made possible and affordable for all clinics, with or without PET or MRI. Installed in treatment rooms, Restitu U/S-Guide(TM) allows for highly accurate patient position verification and alignment, with its proprietary MUTUAL REFERENCING(TM) technology that uses assisted segmentation for efficient and robust intramodality 3D U/S image-guidance.


'/>"/>
SOURCE Resonant Medical inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Ayurvedic Therapies Cashing In On Medical Tourism
4. Robots craft medical history
5. NBE to conduct test for medical students from abroad
6. Air pollution combined with greater medical needs
7. Indian Nationals with Foreign Medical Degrees can now practice in India
8. Children! Protecting them from medical mistakes
9. More information sought by patients on medical errors
10. SARS necessitates medical masks
11. Meditation Works Medically
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
Breaking Medicine Technology: